01.10.13
Seppic, a subsidiary of Air Liquide, reinforces its activity in healthcare specialty ingredients with the acquisition of BiotechMarine. BiotechMarine is a leading player in the design and marketing of active ingredients for the global cosmetics industry.
A subsidiary of the Roullier Group, BiotechMarine specializes in the design and marketing of bio-based, cosmetic active ingredients made from algae. BiotechMarine is based in the west of France, in the town of Pontrieux,
and has 35 employees. Since its creation in 1988, BiotechMarine has been recognized for its know-how, according to Air Liquide.
BiotechMarine offers a complete range of natural active ingredients sold all over the world, which are used in cosmetic products in particular. The acquisition of BiotechMarine gives Seppic complementary expertise in marine
biotechnologies and plant cell culture and widens its product portfolio
with a complete range of active ingredients from marine biodiversity.
"We are delighted to welcome these new employees to the Group. With this acquisition Air Liquide intends to reinforce its position in the field of healthcare specialty ingredients. The complementarity of BiotechMarine and Seppic allows us to widen our knowhow and continue the development of this activity," said Pascal Vinet, VP-healthcare global operations and member of the Group’s Executive Committee. "Health is one of the group's growth drivers."
A subsidiary of the Roullier Group, BiotechMarine specializes in the design and marketing of bio-based, cosmetic active ingredients made from algae. BiotechMarine is based in the west of France, in the town of Pontrieux,
and has 35 employees. Since its creation in 1988, BiotechMarine has been recognized for its know-how, according to Air Liquide.
BiotechMarine offers a complete range of natural active ingredients sold all over the world, which are used in cosmetic products in particular. The acquisition of BiotechMarine gives Seppic complementary expertise in marine
biotechnologies and plant cell culture and widens its product portfolio
with a complete range of active ingredients from marine biodiversity.
"We are delighted to welcome these new employees to the Group. With this acquisition Air Liquide intends to reinforce its position in the field of healthcare specialty ingredients. The complementarity of BiotechMarine and Seppic allows us to widen our knowhow and continue the development of this activity," said Pascal Vinet, VP-healthcare global operations and member of the Group’s Executive Committee. "Health is one of the group's growth drivers."